The core activity of Elibo Health LLC is to provide services in the field of Health Economics, Outcomes Research (HEOR) and Market Access for medical technologies (drugs, gene therapies, medical devices, diagnostic tests) in Switzerland. This includes in particular:
* Supporting the creation of dossiers and price negotiations for the reimbursement of drugs and medical technologies by Swiss authorities (BAG, BSV)
* Developing and communicating evidence-based value messages regarding efficacy, effectiveness, benefit and cost-effectiveness (according to the Swiss WZW criteria)
* Conducting systematic and targeted literature reviews
* Cost-benefit analyses and budget impact analyses
The company offers these services to support companies in obtaining market authorization and acceptance of their medical technologies in Switzerland.